MINI FUTURE LONG - JOHNSON & JOHNSON Share Price

Certificat

DE000PF3GV55

Market Closed - Boerse Frankfurt Warrants 20:50:24 30/04/2024 BST
2.68 EUR -5.30% Intraday chart for MINI FUTURE LONG - JOHNSON & JOHNSON
1 month-30.28%
3 months-32.84%
Date Price Change Volume
30/04/24 2.74 -3.18% 0
29/04/24 2.83 +1.43% 0
26/04/24 2.79 -2.11% 0
25/04/24 2.85 -6.56% 0
24/04/24 3.05 -3.17% 0

Real-time Boerse Frankfurt Warrants

Last update April 30, 2024 at 08:50 pm

More quotes

Static data

Product typeKnock-Out with Stop Loss
Buy / SellCALL
Underlying JOHNSON & JOHNSON
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PF3GV5
ISINDE000PF3GV55
Date issued 21/10/2020
Strike 116.4 $
Maturity Unlimited
Parity 10 : 1
Emission price 3.55
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 7.68
Lowest since issue 2.58

Company Profile

Johnson & Johnson is one of the world's leading producers of healthcare products. Net sales break down by family of products as follows: - pharmaceutical products (55.4%): drugs intended for the treatment of cardiovascular diseases, oncological diseases, gastro-intestinal illnesses, infectious, immunological, neurological, dermatological diseases, etc.; - medical products and equipment (28.9%): diagnostic systems, orthopedic and gynecological equipment, surgical materials, etc. for use by healthcare professionals; - consumer health products (15.7%): OTC drugs (Tylenol, Sudafed, Benadryl, Zyrtec, Motrin, Nicorette and other brands), health and beauty products (Aveeno, Clean & Clear, Dr. CI:Labo, Neutrogena and OGX), baby care products (Johnson's and Aveeno Baby), oral care products (Listerine), feminine hygiene products (Stayfree and Carefree and o.b.), wound care products (Band-Aid and Neosporin) etc. At the end of 2022, Johnson & Johnson has 89 manufacturing facilities located in the United States (28), North America (9), Europe (27), Africa and Asia/Pacific (25). Net sales are distributed geographically as follows: the United States (51.2%), Europe (24.7%), Asia/Pacific and Africa (17.7%) and other (6.4%).
Sector
-
More about the company

Ratings for Johnson & Johnson

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Johnson & Johnson

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
22
Last Close Price
151.2 USD
Average target price
173.3 USD
Spread / Average Target
+14.61%
Consensus